The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1021
February 27, 1998
View Complete Issue         Table of Contents 2019 
Zolmitriptan for Migraine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Zolmitriptan for Migraine
February 27, 1998 (Issue: 1021)
Zolmitriptan (Zomig - Zeneca), a selective serotonin (5-HT1)-receptor agonist, is now available in the USA for oral treatment of migraine headache. Zomitriptan structurally resembles sumatriptan (Imitrex - Medical Letter 34:91, 1992). Drugs currently...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Zolmitriptan for Migraine
Article code: 1021b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.